On March 11, 2020, the World Health Organization declared its assessment of coronavirus
disease 2019 (COVID‐19) as a global pandemic. However, specific anti‐severe acute …

Abstract Coronavirus disease-2019 (COVID-19) is associated with severe inflammation in
mainly the lung, and kidney. Reports suggest a beneficial effect of the use of heparin/low …

Background This study was conducted to evaluate the impact of low-molecular-weight
heparin (LMWH) on the outcome of patients with severe acute respiratory syndrome …

Background Heparin administration in COVID-19 patients is recommended by expert
consensus, although evidence about dosage, duration and efficacy are limited. We aim to …

Background Coronavirus infectious disease 2019 (COVID-19) has developed into a global
pandemic. It is essential to investigate the clinical characteristics of COVID-19 and uncover …

The pandemic coronavirus disease 2019 (COVID-19), caused by the infection of severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is rapidly spreading globally …

The impact of the COVID-19 pandemic has been dramatic worldwide, with China, Italy, and
now US at its epicenter. Researchers and clinicians are studying and testing different …

Coronavirus disease 2019 (COVID-19), the clinical syndrome associated with infection by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has impacted nearly every …

COVID-19 is spreading worldwide at disturbing rates, overwhelming global healthcare.
Mounting death cases due to disease complications highlight the necessity of describing …

Introduction A hypercoagulable condition was described in patients with coronavirus
disease 2019 (COVID-19) and proposed as a possible pathogenic mechanism contributing …